Treatment outcome in chronic hepatitis C infection: a four years survey among Iranian patients

Global journal of health science

Volumn 7, Issue 3, 2015, Pages 75-81

  Hajiaghamohammadi, Aliakbar ^a   Samimi, Rasoul ^a   Miroliaee, Arash ^a   Kazemifar, Amir M ohammad ^b   Nazem, Masoumeh ^b  

^a Qazvin university of medical sciences drhoushmand@yahoocom ^*

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN;

ADULT; AGED; CROSS-SECTIONAL STUDY; DRUG COMBINATION; FEMALE; GENETICS; GENOTYPE; HEPATITIS C, CHRONIC; HUMAN; IRAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; IRAN; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84937217371     PISSN: 19169736     EISSN: None     Source Type: Journal    
DOI: 10.5539/gjhs.v7n3p75     Document Type: Article

References (0)